Thanks, pmrider. Great stuff. The press release was plural. MedImmune is taking more than one compound across the BBB. They're serious. This could be way bigger for BTI than Shire.

.

For a long time I've been touting a buyout rather than licensing deals. We'd get quick money, we could move on to something else, another 5 or 10 bagger, no waiting. I don't think that any longer. I agree with BFW earlier post on this. BTI is being set up for a great run, I think. Pmrider, you and I have talked about these things many times and I have always appreciated your use of the word "stickup." That's exactly what it is. A "mugging" flows off the tongue nicely for me.

.

There is going to come a moment when investors realize that the pharmas MUST come to BTI. Yes the pain management market could be $30 billion. MedImmune could have a great treatment but if they can't deliver the drug where it needs to be, they're pretty much out of it, or at least won't have a big part of it. Shire could lose their LSD business if they don't make a deal soon. What is Abbott doing? Who might be interested in BTI2111?

.

And, is there another pharma or two or three or four already talking to BTI?

.

I say a run on this stock is imminent. No idea how high it could go on a quick run but to $4 to $5 is possible. Of course, if Rob Hutchison can deliver a Shire deal first, then who knows where this could go.

.